Syra Health Corp. Class A Common Stock Total Liabilities

Latest as of March 2026: $1.58 Million USD

Syra Health Corp. Class A Common Stock total liabilities. Based on the latest financial reports, Syra Health Corp. Class A Common Stock (SYRA) has total liabilities worth $1.58 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See SYRA defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Syra Health Corp. Class A Common Stock (2020–2025)

Total liabilities of Syra Health Corp. Class A Common Stock from 2020 to 2025. This chart illustrates how Syra Health Corp. Class A Common Stock's total liabilities have evolved over time, based on quarterly financial data.

Syra Health Corp. Class A Common Stock Competitors by Total Liabilities

The table below lists competitors of Syra Health Corp. Class A Common Stock ranked by their total liabilities.

Company Country Total Liabilities
Kaili Resources Ltd
AU:KLR
Australia AU$5.39 Million
Luminar Technologies
NASDAQ:LAZR
USA $505.08 Million
National Plastic Co Ltd Preferred
KO:004255
Korea ₩168.34 Billion
Euro Manganese Inc
AU:EMN
Australia AU$34.27 Million
21st Century Management Services Limited
NSE:21STCENMGM
India Rs64.99 Million
Infrared Cameras Holdings Inc
NASDAQ:MSAI
USA $3.44 Million
Thor Energy Plc
AU:THR
Australia AU$273.51K
Pantheon Infrastructure PLC
LSE:PINT
UK GBX6.12 Million

Liability Composition Analysis (2020–2025)

This chart breaks down Syra Health Corp. Class A Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see SYRA asset base.

Liquidity & Leverage Metrics

Syra Health Corp. Class A Common Stock Total Liabilities Ratios Explained

Syra Health Corp. Class A Common Stock total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 2.48 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.67 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.40 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Syra Health Corp. Class A Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Syra Health Corp. Class A Common Stock (2020–2025)

The table below shows the annual total liabilities of Syra Health Corp. Class A Common Stock from 2020 to 2025.

Year Total Liabilities Change
2025-12-31 $674.74K -15.74%
2024-12-31 $800.76K -12.01%
2023-12-31 $910.07K -43.46%
2022-12-31 $1.61 Million +195.85%
2021-12-31 $544.04K +7490.85%
2020-12-31 $7.17K --

About Syra Health Corp. Class A Common Stock

NASDAQ:SYRA USA Medical Care Facilities
Market Cap
$8.96 Million
Market Cap Rank
#27950 Global
#5765 in USA
Share Price
$0.79
Change (1 day)
+1.28%
52-Week Range
$0.06 - $1.05
All Time High
$4.85
About

Syra Health Corp., a healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education and training, and healthcare workforce development and staffing in the United States. The company offers Syrenity, a behavioral and mental health application that identifies and prevents the progression of negative factors that can influence ind… Read more